Evidence map›Paper›PMID 30338480›Full record

ArticleEndocrine2019

High prevalence of adrenal insufficiency at diagnosis and headache recovery in surgically resected Rathke's cleft cysts-a large retrospective single center study.

Fabienne Langlois, Anamaria Manea, Dawn Shao Ting Lim, Shirley McCartney, Christine G Yedinak, Justin S Cetas, Maria Fleseriu

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The endocrine spectrum of Rathke cleft cysts.Frontiers in endocrinology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease.The Journal of clinical endocrinology and metabolism · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Fabienne Langlois *Department of Endocrinology, Centre hospitalier universitaire de Sherbrooke, Fleurimont, QC, Canada.
Anamaria Manea *Pediatric Endocrinology, Oregon Health & Science University, Portland, OR, USA.
Dawn Shao Ting LimDepartment of Endocrinology, Singapore General Hospital, Singapore, Singapore.
Shirley McCartneyNeurological Surgery, Oregon Health & Science University, Portland, OR, USA.
Christine G YedinakNeurological Surgery, Oregon Health & Science University, Portland, OR, USA.
Justin S CetasNeurological Surgery, Oregon Health & Science University, Portland, OR, USA.
Maria FleseriuNeurological Surgery, Oregon Health & Science University, Portland, OR, USA. fleseriu@ohsu.edu.
Oregon Health & Science University · USCentre Hospitalier Universitaire de Sherbrooke · CASingapore General Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRathke's cleft cysts (RCC) are lesions that arise from Rathke's pouch. Though frequently incidental, resulting symptoms in a minority of cases are indicators for surgical resection, which may prove beneficial.

objectiveTo characterize a cohort of surgically-resected RCC cases at Oregon Health & Science University; tabulate associated hormonal imbalances and symptoms, possible symptom reversal with surgery, determine recurrence risk; identify predictors of recurrence and headache improvement.

methodElectronic records of all RCC resected cases (from 2006-2016; 11 years) were retrospectively reviewed. Patients had been evaluated by one neuroendocrinologist using a uniform protocol.

resultsA pathological RCC diagnosis was established in 73 of 814 (9%) surgical pituitary cases. The RCC cohort was 77% (n = 56/73) female, mean age was 39.5 ± 14.9 years at first surgery, and at presentation headache was reported in 88% and visual defects/diplopia in 18% of patients. Initial RCC maximum diameter was 1.3 ± 0.7 cm. The most frequent hormonal deficit was cortisol; 24% of patients had a new adrenal insufficiency (AI) diagnosis, however, 36% also had AI at 3 months post-operatively. Mean follow up was 4.0 ± 4.5 years. Two-thirds of patients (41/62) had headache improvement 3 months post-operatively. Post-operative imaging revealed no residual cyst in 58% (38/65). In those patients with no residual RCC, 29% had recurrence and 71% had long lasting cure. From the 42% (27/65) of patients with residual cyst on post-operative imaging; 59% (16/27) remained stable, 26% (7/27) progressed and 15% (4/27) regressed.

conclusionSymptomatic RCC present mostly in women, with a high proportion reporting headaches. Prevalence of AI at diagnosis is high. Surgery may not achieve adrenal axis recovery, but renders a high percentage of headache improvement. Approximately 25% of RCC will recur by 4 years postoperatively. Clinicians should cautiously screen patients with symptomatic RCC, regardless of lesion size for AI.

Indexed as

AdolescentAdrenal InsufficiencyAdultAgedCentral Nervous System CystsChildFemaleHeadacheHumansMaleMiddle AgedOregonPrevalenceRetrospective StudiesTreatment OutcomeYoung AdultAdrenal insufficiencyHeadachePituitary cystPituitary lesionsRathke’s cleft cystsTranssphenoidal surgery

Identifiers

PMID30338480
OpenAlexW2895937521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.